Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2003 Jun 01;1393:567-74. doi: 10.1038/sj.bjp.0705283.
Show Gene links
Show Anatomy links
The antipsychotic drug chlorpromazine inhibits HERG potassium channels.
Thomas D
,
Wu K
,
Kathöfer S
,
Katus HA
,
Schoels W
,
Kiehn J
,
Karle CA
.
???displayArticle.abstract???
(1) Acquired long QT syndrome (aLQTS) is caused by prolongation of the cardiac action potential because of blockade of cardiac ion channels and delayed repolarization of the heart. Patients with aLQTS carry an increased risk for torsade de pointes arrhythmias and sudden cardiac death. Several antipsychotic drugs may cause aLQTS. Recently, cases of QTc prolongation and torsade de pointes associated with chlorpromazine treatment have been reported. Blockade of human ether-a-go-go-related gene (HERG) potassium channels, which plays a central role in arrhythmogenesis, has previously been reported to occur with chlorpromazine, but information on the mechanism of block is currently not available. We investigated the effects of chlorpromazine on cloned HERG potassium channels to determine the biophysical mechanism of block. (2) HERG channels were heterologously expressed in Xenopus laevis oocytes, and ion currents were measured using the two-microelectrode voltage-clamp technique. (3) Chlorpromazine blocked HERG potassium channels with an IC(50) value of 21.6 micro M and a Hill coefficient of 1.11. (4) Analysis of the voltage dependence of block revealed a reduction of inhibition at positive membrane potentials. (5) Inhibition of HERG channels by chlorpromazine displayed reverse frequency dependence, that is, the amount of block was lower at higher stimulation rates. No marked changes in electrophysiological parameters such as voltage dependence of activation or inactivation, or changes of the inactivation time constant were observed. (6) In conclusion, HERG channels were blocked in the closed and activated states, and unblocking occurred very slowly.
Dorson,
Chlorpromazine accumulation and sudden death in a patient with renal insufficiency.
1988, Pubmed
Dorson,
Chlorpromazine accumulation and sudden death in a patient with renal insufficiency.
1988,
Pubmed
Drolet,
Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current.
1999,
Pubmed
Ficker,
Molecular determinants of dofetilide block of HERG K+ channels.
1998,
Pubmed
,
Xenbase
Ficker,
Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome.
2000,
Pubmed
,
Xenbase
Glassman,
Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
2001,
Pubmed
Haddad,
Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
2002,
Pubmed
Hoehns,
Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias.
2001,
Pubmed
Kang,
Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.
2001,
Pubmed
Karle,
Antiarrhythmic drug carvedilol inhibits HERG potassium channels.
2001,
Pubmed
,
Xenbase
Kiehn,
Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
1999,
Pubmed
,
Xenbase
Kiehn,
Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide.
1996,
Pubmed
,
Xenbase
Lee,
Chlorpromazine-induced inhibition of catecholamine secretion by a differential blockade of nicotinic receptors and L-type Ca2+ channels in rat pheochromocytoma cells.
1999,
Pubmed
Mitcheson,
Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate.
2000,
Pubmed
,
Xenbase
Naccarelli,
Amiodarone: clinical trials.
2000,
Pubmed
Napolitano,
Torsade de pointes. Mechanisms and management.
1994,
Pubmed
Quamme,
Chlorpromazine activates chloride currents in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Reilly,
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.
2000,
Pubmed
Sanguinetti,
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
1995,
Pubmed
,
Xenbase
Smith,
The inward rectification mechanism of the HERG cardiac potassium channel.
1996,
Pubmed
Suessbrich,
Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
1996,
Pubmed
,
Xenbase
Suessbrich,
The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Teschemacher,
Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
1999,
Pubmed
Thomas,
Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A.
1999,
Pubmed
,
Xenbase
Thomas,
The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels.
2002,
Pubmed
,
Xenbase
Thomas,
High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
2001,
Pubmed
,
Xenbase
Tie,
The heart of psychotropic drug therapy.
2000,
Pubmed
Tokunaga,
Plasma concentrations of antipsychotic drugs in psychiatric inpatients.
1997,
Pubmed
Viskin,
Long QT syndromes and torsade de pointes.
1999,
Pubmed
Warmke,
A family of potassium channel genes related to eag in Drosophila and mammals.
1994,
Pubmed
Zitron,
Bertosamil blocks HERG potassium channels in their open and inactivated states.
2002,
Pubmed
,
Xenbase
